SCRI Tennessee Oncology — Nashville, Tennessee

SCRI Tennessee Oncology is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 68/100 (FAIR). This profile has not yet been claimed by the site owner.

SCRI Tennessee Oncology has participated in 3 clinical trials.

Therapeutic areas: Leukemia, Myeloid, Acute, AML, Non-small Cell Lung Cancer.

Sponsors: PTC Therapeutics, Genentech, Inc., Kronos Bio.

Sponsor Feasibility Report

Trust Score: 68/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for SCRI Tennessee Oncology?

SCRI Tennessee Oncology has a Crixeo Trust Score of 68/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has SCRI Tennessee Oncology conducted?

SCRI Tennessee Oncology has 3 clinical trials on record. Their work covers Leukemia, Myeloid, Acute, AML, Non-small Cell Lung Cancer.

Is SCRI Tennessee Oncology accredited by Crixeo Health?

SCRI Tennessee Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about SCRI Tennessee Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.